Becq; Frederic

Patent Applications and Registrations

Patent applications and USPTO patent grants for Becq; Frederic.The latest application filed is for "compounds for treating cystic fibrosis".

Company Profile

1.10.9

Becq; Frederic - La Chapelle Montreuil FR
Becq; Frederic - Poitiers FR
Becq; Frederic - Bonnes FR
Becq; Frederic - Saint Benoit FR
Becq; Frederic - Aix en Provence FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds for treating cystic fibrosis Grant 10,414,768 - Callebaut , et al. Sept	2019-09-17
Compounds For Treating Cystic Fibrosis App 20170362239 - CALLEBAUT; Isabelle ; et al.	2017-12-21
Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells Grant 8,492,420 - Becq , et al. July 23, 2	2013-07-23
Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells Grant 8,252,958 - Becq , et al. August 28, 2	2012-08-28
Use of glucosidase inhibitors for therapy of mucovisidosis Grant 8,242,136 - Becq , et al. August 14, 2	2012-08-14
Use Of Glucosidase Inhibitors For Therapy Of Mucovisidosis App 20110269795 - BECQ; Frederic ; et al.	2011-11-03
Use of glucosidase inhibitors for therapy of mucovisidosis Grant 7,973,054 - Becq , et al. July 5, 2	2011-07-05
Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction Grant 7,897,610 - Becq , et al. March 1, 2	2011-03-01
CFTR channel modulators Grant 7,772,198 - Decout , et al. August 10, 2	2010-08-10
Use of Guanabenz and Its Derivatives for Making Drugs for Treating Cystic Fibrosis and Diseases Related to a Protein Addressing Deficiency in the Cells App 20090306430 - Becq; Frederic ; et al.	2009-12-10
Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells Grant 7,605,153 - Becq , et al. October 20, 2	2009-10-20
Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells App 20090048260 - Becq; Frederic ; et al.	2009-02-19
Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells App 20080076756 - Becq; Frederic ; et al.	2008-03-27
Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells App 20070275986 - Becq; Frederic ; et al.	2007-11-29
Use of Glucosidase Inhibitors for Therapy of Mucovisidosis App 20070213357 - Becq; Frederic ; et al.	2007-09-13
CFTR channel modulators App 20060258612 - Decout; Jean-Luc ; et al.	2006-11-16
Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction App 20050176747 - Becq, Frederic ; et al.	2005-08-11
CFTR channel activator compounds and pharmaceutical compositions containing same Grant 6,630,482 - Becq , et al. October 7, 2	2003-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.